SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Shares are surging on heavy speculation after founder Patrick Soon-Shiong teased launching blockchain-based tokenized stock trading at Nant, with bullish traders framing potential IBRX tokenization as a curb on naked shorting that could pressure the heavily shorted float, while skeptics dismiss it as a hype-driven distraction from Anktiva's regulatory pipeline. Community chatter about Soon-Shiong meeting Turkey's president during the UN General Assembly is also fueling speculation of an Anktiva approval or expansion in Turkey, though no such announcement has been confirmed.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is moving after CEO Ryan Cohen disclosed another open-market purchase of more than 1.1 million shareshis second sizable buy in recent weekssending the stock higher in extended and premarket trading. Traders are largely bullish, treating the insider buying, along with additional director purchases, as a conviction signal and speculating it aims to push shares toward the warrant exercise threshold before expiration, though some argue the price response has been muted for the size of the buy and skeptics still raise dilution and pump-and-dump concerns.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is drawing heavy attention after positive topline results from a VK2735 maintenance study showed patients retained up to 97% of prior weight loss on every-other-week dosing and up to 90% on monthly dosing, with roughly 22% placebo-adjusted weight loss after 33 weeks and no observed plateau. Bulls hail the obesity drug as best-in-class against Eli Lilly and Novo Nordisk treatments, fueling buyout and partnership speculation plus short-squeeze hopes amid elevated short interest, while skeptics point to a comparatively muted stock reaction, potential dilution from a previously filed shelf offering, and unresolved questions around lean mass preservation.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk's removal from the S&P 500 and transition to the S&P SmallCap 600 is dominating the conversation, as traders parse unusually heavy rebalancing volume and debate whether forced selling by passive index funds has been fully absorbed or marks another leg lower. Sentiment is heavily bearish, with much of the anger directed at CEO Jeff Green over option repricing and executive stock awards amid the stock's prolonged collapse, though some contrarians are buying the weakness citing oversold conditions and elevated short interest.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending on its first design win for Alloy Kore, the QNX- and Vector-developed foundational vehicle OS selected by Coretura, the software-defined vehicle platform venture founded by Daimler Truck and Volvo Group  a deal the company said adds a nine-figure amount to the QNX royalty backlog and ranks as QNX's largest design win on record. Bulls are hailing it as long-awaited validation of the QNX growth story heading into Q2 results, while other traders are frustrated by the stock's weak reaction to the news, citing sell-the-news dynamics and alleged manipulation, and debating how soon the win translates into revenue given that contract timing was not disclosed.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

A cluster of open-market insider purchases  CEO John Fieldly followed by two directors in rapid succession  is the dominant driver of attention, with bulls framing the consecutive buys as a strong conviction signal near the lows and possible fuel for a short squeeze, while skeptics call the purchases small relative to insiders' existing stakes and note weak price follow-through. Speculation that the buying signals activist pressure or positioning ahead of a Pepsi takeover bid circulates alongside persistent criticism of management over the core brand's slowdown, though these theories remain unconfirmed.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

A sharp sell-off in Cisco shares is being attributed by traders to Piper Sandler lowering its price target on the stock while keeping a Neutral rating, with some users arguing it was merely a target cut rather than a true downgrade. Much of the community views the drop as an overreaction or blames institutions for using the cut to shake out retail buyers, fueling dip-buying calls, while others expect the stock to keep sliding as it works to fill its gap.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Traders are reacting to a sharp sell-off in Fastly following its Investor Day, where management projected roughly 18% annual revenue growth over the next three yearsa figure some view as deliberately conservative and others as underwhelming after the stock's run-up into the event. The community is split between treating the drop as an algorithm-driven 'sell-the-news' overreaction worth dip-buying and expecting a retest of lower support levels.

Goodyear Tire & Rubber Co. engages in the development, manufacture, distribution, and sale of tires. It operates through the following geographical segments: Americas, Europe, Middle East, and Africa, and Asia Pacific. The Americas segment is involved in the development, manufacture, distribution, and sale of tires and related products and services in North, Central, and South America. The Europe, Middle East, and Africa segment focuses on the development, manufacture, distribution, and sale of tires for automobiles, trucks, buses, aircraft, motorcycles, earthmoving, mining, and industrial equipment throughout Europe, the Middle East, and Africa. The Asia Pacific segment refers to the development, manufacture, distribution, and sales of tires for automobiles, trucks, buses, aircraft, farm, earthmoving, mining, and industrial equipment throughout the Asia Pacific region. The company was founded by Frank A. Seiberling on August 29, 1898 and is headquartered in Akron, OH.

Goodyear Tire & Rubber Co.

Goodyear is drawing heavy attention after a sharp rally, with traders speculating about a potential buyout or takeover  repeatedly name-dropping David Tepper and other possible buyers  and arguing elevated short interest could fuel a squeeze. The pop has divided the community between bulls calling the stock deeply undervalued relative to its revenue scale and skeptics citing its heavy debt load and the monthlong selling pressure that had occurred with no company news to justify it.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

HIMS is drawing heavy attention as the stock breaks above a resistance level that had repeatedly capped it, with bulls framing the move as the start of a potential short squeeze given elevated short interest and a retail push to pull shares out of lending programs, while skeptics dismiss it as another low-volume fakeout after weeks of failed breakouts. Discussion is also building around anticipated catalysts, including possible FDA peptide approval, a planned app overhaul, and the company's expansion into Australia.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Timothy Plan - Timothy Plan US Small Cap Core ETF

Bullish Sentiment

Job displacement

Market bubble / overvaluation

Loss of human oversight / control

Killer robots 🤖

As AI spending accelerates across hyperscalers and valuations climb to historic highs, investors and workers alike are increasingly debating the risks the technology poses - from job displacement to fears about losing human oversight over increasingly autonomous systems. What do you think is the biggest threat AI poses? Vote and explain your reasoning in the comments.

Current Price	$45.81
Prev Close	$45.67
Open	$46.02
Dividend Yield	N/A
50-Day Moving Average	$47.77
Beta	N/A
Avg. Volume	30,948.98
PE Ratio	N/A

52-Week High	$49.36
52-Week Low	$39.04
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

TPSC Fundamentals